MOLLY BROWN: Open Payments
NPI 1033464508 · BILOXI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 20 payments from 7 companies in 2025. Trend: 2023 $508 · 2024 $589 · 2025 $332
Food & beverage: $332
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $117 |
| AstraZeneca Pharmaceuticals LP | 5 | $80 |
| ABBVIE INC. | 4 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| PFIZER INC. | 1 | $14 |
Products named: MOUNJARO, AIRSUPRA, VRAYLAR, CAPLYTA, QULIPTA, Cologuard Collection Kit, CONTRAVE, FARXIGA.
Industry payments across MS — which companies pay providers there.
